** Shares in Clariant CLN.S are down 3.2% after the Swiss speciality chemicals maker flagged lower demand and higher costs linked to the war in Iran after reporting lower-than-expected earnings
** Clariant kept its guidance for the year unchanged but said the war was causing higher input costs, and overall elevated uncertainty and volatility
** Adjusted for exceptional items, EBITDA fell 16% yoy, slightly below analysts' forecast
** "The markets and the Middle East conflict do
not support better results," Vontobel says
** The broker adds that the ethylene lawsuit is also weighing on the company
(Reporting by Bartosz Dabrowski in Gdansk)
((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))